PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
27-Jan-2026 Evestia Clinical Acquires ICRC-Weyer to Enhance Global Full-Service Clinical Research Capabilities Evestia Clinical
27-Jan-2026 Astoriom Acquires Precision Stability Storage Astoriom
27-Jan-2026 Robocath launches First-In-Human (FIH) clinical study of second-generation robot with unique capabilities in coronary artery disease Andrew Lloyd Associates
26-Jan-2026 Ellipses in-licenses first-in-class B7H3 antibody drug conjugate from China Ellipses Pharma
26-Jan-2026 Clavulanic Acid Market Set to Surge to USD 1,800 Million by 2035, Robust Growth Fueled by Rising Antibiotic Resistance and Healthcare Expansion Acumen Research And Consulting
22-Jan-2026 Infinitopes Expands Seed Financing to $35 Million to Accelerate Clinical Development of Precision Cancer Vaccine Infinitopes
22-Jan-2026 Hansa Biopharma has won the 2025 SwedenBIO Award Hansa Biopharma
22-Jan-2026 Dawnzera™ (donidalorsen) granted European Union marketing authorisation for the prevention of hereditary angioedema Otsuka
22-Jan-2026 Resolve M Therapeutics exits from stealth Resolve M Therapeutics
22-Jan-2026 Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA) PulseSight Therapeutics
21-Jan-2026 Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab Tiziana Life Sciences
21-Jan-2026 Opdivo® (nivolumab) with chemotherapy before surgery then alone after surgery recommended for use on the NHS when treating adult patients with resectable NSCLC BMS
21-Jan-2026 ErVimmune raises €17 million in Series A first closing to enter clinical development with lead cancer vaccine candidate ErVimmune
21-Jan-2026 Angelini Pharma announces Appointment of Sergio Marullo di Condojanni as New CEO Angelini Pharma
21-Jan-2026 ErVimmune raises €17 million in Series A first closing to enter clinical development with lead cancer vaccine candidate Andrew Lloyd Associates
21-Jan-2026 Cathpax, with its new Nova-X system, demonstrates its ability to offer interventional physicians an unmatched level of radiation protection to prevent all radiation-induced diseases and musculoskeletal disorders,thanks to a first-of-its-kind clinical study Andrew Lloyd Associates
20-Jan-2026 ELRIG Announces Drs Stephen Ward and Annarita Miccio as Keynote Speakers for Cell and Gene Therapy 2026 ELRIG
20-Jan-2026 Brainomix e-Lung AI Imaging Technology Selected as Co-Primary Endpoint in Boehringer Ingelheim Phase 3 Clinical Trial in Pulmonary Fibrosis Brainomix
20-Jan-2026 Brainomix e-Lung AI Imaging Technology Selected as Co-Primary Endpoint in Boehringer Ingelheim Phase 3 Clinical Trial in Pulmonary Fibrosis Brainomix
20-Jan-2026 Exciva raises €51 million ($59m) in Series B funding round co-led by Gimv and EQT Exciva